Moneycontrol PRO

Ashwin Mohan

Deputy Editor - Deals

Moneycontrol

Exclusive | Tata Power prepares to launch rights issue along with infra trust to cut debt

BUSINESS

Exclusive | Tata Power prepares to launch rights issue along with infra trust to cut debt

India’s largest private integrated power company’s rights issue could be upwards of Rs 2,000 crore. Tata Power to join similar fundraising efforts of companies such as RIL, M&M Financial Services, Future Consumer and Aditya Birla Fashion & Retail.

Standard Life launches fresh $260 million block deal in HDFC Life; second stake sale in a day

BUSINESS

Standard Life launches fresh $260 million block deal in HDFC Life; second stake sale in a day

Earlier in the day, in a separate block deal, Standard Life sold 1.3 percent stake in HDFC Life Insurance in a separate block deal.

US endowment fund Regents, Oppenheimer top buyers in Uday Kotak's mega Rs 6,900-crore block deal

BUSINESS

US endowment fund Regents, Oppenheimer top buyers in Uday Kotak's mega Rs 6,900-crore block deal

The second highest buyer of shares was Oppenheimer Developing Markets Fund.

Exclusive | PE firm ChrysCapital to buy out Capital International's stake in Intas Pharmaceuticals

BUSINESS

Exclusive | PE firm ChrysCapital to buy out Capital International's stake in Intas Pharmaceuticals

Capital International wanted to exit the firm because its parent Capital Group is looking to shift focus away from the private equity vertical.

Exclusive | Kishore Biyani's Future Lifestyle Fashions looks to raise Rs 200-225 crore via rights or preference issue

BUSINESS

Exclusive | Kishore Biyani's Future Lifestyle Fashions looks to raise Rs 200-225 crore via rights or preference issue

The listed entity, which counts consumer focused private equity firm L Catterton Asia, Azim Premji's investment arm Premji Invest and the world's largest alternative asset manager Blackstone among its investors, has been hit hard by store closures due to the extended nationwide lockdown.

KKR India's Sanjay Nayar on Jio deal: See potential for collaborations with portfolio companies

BUSINESS

KKR India's Sanjay Nayar on Jio deal: See potential for collaborations with portfolio companies

In this interview with Moneycontrol, he sheds light on the investment thesis behind the mega deal, potential synergies within the KKR global portfolio and digital buyout opportunities in India.

Multiplex chain PVR planning rights issue; Warburg Pincus and Multiples PE may participate

BUSINESS

Multiplex chain PVR planning rights issue; Warburg Pincus and Multiples PE may participate

PVR Cinemas has appointed Axis Capital as the merchant banker for the proposed rights issue, a source told Moneycontrol.

General Atlantic's Sandeep Naik: Jio is uniquely positioned to democratise data and digital services

BUSINESS

General Atlantic's Sandeep Naik: Jio is uniquely positioned to democratise data and digital services

General Atlantic, which invested Rs 6,600 crore in RIL digital unit, says it will support Jio team as they look to solve needs of Bharat and leverage connectivity

Carlyle and former Mylan top executive in talks to buy Ra Chem Pharma from Micro Labs

BUSINESS

Carlyle and former Mylan top executive in talks to buy Ra Chem Pharma from Micro Labs

The Carlyle-Hari Babu consortium is in advanced stages of negotiations to buy out Hyderabad-based API ( active pharmaceutical ingredients) maker Ra Chem Pharma from majority stakeholder and parent Micro Labs.

Why Vedanta is delisting on the Indian stock exchanges now, explained

BUSINESS

Why Vedanta is delisting on the Indian stock exchanges now, explained

Understanding the rationale behind metals and mining billionaire Anil Agarwal's decision to buy out minority, non-promoter shareholders of his Indian unit and take it private.

Kotak Mahindra Bank, Hero FinCorp and True North in race for Future’s stake in general insurance JV

BUSINESS

Kotak Mahindra Bank, Hero FinCorp and True North in race for Future’s stake in general insurance JV

Mumbai-headquartered Future, India’s largest retail firm, holds a 50 percent stake in Future Generali India Insurance, which commenced operations in 2007.

Reliance Jio's new investor Silver Lake is quite the 'sport'

BUSINESS

Reliance Jio's new investor Silver Lake is quite the 'sport'

Silver Lake backs some of the biggest global brands in sports entertainment ranging from football to mixed martial arts to live venue services

Exclusive | L&T Mutual Fund: GA-backed IIFL Wealth, HDFC AMC, Blackstone and DSP Group in the fray

BUSINESS

Exclusive | L&T Mutual Fund: GA-backed IIFL Wealth, HDFC AMC, Blackstone and DSP Group in the fray

The engineering to software conglomerate, which houses L&T Mutual Fund under listed arm L&T Finance, had put the mutual fund business on the block earlier in a renewed attempt to find a suitable buyer

Exclusive | KKR leads race to buy stake in Piramal's pharma business

BUSINESS

Exclusive | KKR leads race to buy stake in Piramal's pharma business

The stake-sale process is aimed at raising growth capital and strengthening the Piramal group’s balance sheet.

New FDI law covering Chinese investments sends dealmakers into a tizzy

BUSINESS

New FDI law covering Chinese investments sends dealmakers into a tizzy

Apart from investments in specific sectors, government nod was required only for investments originating from Pakistan and Bangladesh

Facebook deal to accelerate Reliance Jio's listing push

BUSINESS

Facebook deal to accelerate Reliance Jio's listing push

The gargantuan all-cash investment of Rs 43,500 crore is a vindication of Mukesh Ambani’s big bet on Jio not as a telecom company but as a tech and platform player.

Coronavirus impact: Indian PE and VC investments as well as exits headed for sharp drop in 2020, says EY

BUSINESS

Coronavirus impact: Indian PE and VC investments as well as exits headed for sharp drop in 2020, says EY

PEs and VCs are expected to focus on the business continuity of their portfolio companies and rely on private investments in public equity transactions in the near term, said EY in a new report

Carlyle to sell stake in Metropolis Healthcare via block deal

BUSINESS

Carlyle to sell stake in Metropolis Healthcare via block deal

Carlyle is pressing ahead to sell its shares in the firm through its subsidiary firm CA Lotus Investments, said a source.

Exclusive | Vineet Mittal-backed Avaada Energy eyeing up to $250m fund-raise

BUSINESS

Exclusive | Vineet Mittal-backed Avaada Energy eyeing up to $250m fund-raise

The renewable energy firm is open to diluting minority stake, wants the money to expand and also bid for renewable energy assets, say sources.

Exclusive | ITC looks to add spice maker Sunrise Foods to its menu

BUSINESS

Exclusive | ITC looks to add spice maker Sunrise Foods to its menu

An exclusivity agreement has been signed between both parties and the deal valuation is pegged in the range of Rs 2,000-2,500 crore

Exclusive | Edelweiss in talks to raise capital in advisory vertical; demerger & listing next on cards

BUSINESS

Exclusive | Edelweiss in talks to raise capital in advisory vertical; demerger & listing next on cards

The promoters are in advanced talks with global funds to sell a minority stake in the Edelweiss Global Investment Advisors or advisory vertical and raise around Rs 400-Rs 500 crore.

Exclusive | L&T revives plans to sell MF business; ropes in JP Morgan as advisor

BUSINESS

Exclusive | L&T revives plans to sell MF business; ropes in JP Morgan as advisor

The move is part of L&T's drive for the past few years to monetise its non-core segments and businesses and become a leaner and meaner conglomerate

Everstone Capital to exit Ashok Leyland-promoted Hinduja Leyland Finance

BUSINESS

Everstone Capital to exit Ashok Leyland-promoted Hinduja Leyland Finance

Everstone Capital is poised to make a full exit of its existing stake in Hinduja Group's NBFC arm, Hinduja Leyland Finance.

Exclusive: Piramal Enterprises eyeing $500 mn fund raise; appoints Rothschild for pharma stake sale

BUSINESS

Exclusive: Piramal Enterprises eyeing $500 mn fund raise; appoints Rothschild for pharma stake sale

The pharma segment contributed Rs 4,786 crores or 36% of the group’s revenues of Rs 13215 crores in FY19.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347